Dashboard
Manage Tickers

TEVA TEVA PHARMACEUTICAL INDUSTR...

NYSE tevapharm.com


$ 19.10 $ 0.05 (0.26 %)    

Thursday, 23-Oct-2025 18:08:04 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 611.70 $ 5.09 (0.84 %)
DIA $ 467.20 $ 1.51 (0.32 %)
SPY $ 672.21 $ 3.96 (0.59 %)
TLT $ 91.38 $ -0.63 (-0.68 %)
GLD $ 378.90 $ 1.51 (0.4 %)
$ 19.02
$ 19.07
$ 19.03 x 100
$ 19.21 x 30
$ 18.85 - $ 19.19
$ 12.47 - $ 22.80
5,670,286
na
21.82B
$ 0.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-30-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 02-05-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 07-31-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-12-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 02-10-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 07-27-2022 06-30-2022 10-Q
14 05-03-2022 03-31-2022 10-Q
15 02-09-2022 12-31-2021 10-K
16 10-27-2021 09-30-2021 10-Q
17 07-28-2021 06-30-2021 10-Q
18 04-28-2021 03-31-2021 10-Q
19 02-10-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-05-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 02-21-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
26 05-02-2019 03-31-2019 10-Q
27 02-19-2019 12-31-2018 10-K
28 11-01-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-03-2018 03-31-2018 10-Q
31 02-12-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Teva Pharmaceutical's Unit Enters License ...
10/20/2025 20:31:32

Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE:AND) entered into a license ...

scisparc-expands-biotech-ambitions-buys-stake-in-miza-iii-ventures
SciSparc Expands Biotech Ambitions, Buys S...
10/15/2025 13:34:30

SciSparc traded higher after the company announced it had signed a definitive agreement to acquire a controlling stake in Miza ...

teva-pharmaceuticals-announces-fda-approves-uzedy-as-first-subcutaneous-long-acting-risperidone-for-maintenance-treatment-of-bipolar-i-disorder-and-schizophrenia
Teva Pharmaceuticals Announces FDA Approve...
10/10/2025 19:01:29

FDA approves UZEDY® (risperidone) extended-release injectable suspension for subcutaneous use as monotherapy or as adjunctive t...

teva-viatris-on-investor-watch-as-white-house-spares-generic-drugs-from-tariffs
Teva, Viatris On Investor Watch As White H...
10/09/2025 13:31:09

The Trump administration backs off plans to impose tariffs on generic drugs after internal debate over price impacts and supply...

scisparc-and-automax-call-off-merger
SciSparc And AutoMax Call Off Merger
10/06/2025 12:55:03

SciSparc ends merger with AutoMax, sets loan repayment terms, and refocuses on CNS drug development and innovation.

jp-morgan-maintains-overweight-on-teva-pharmaceutical-indus-raises-price-target-to-26
JP Morgan Maintains Overweight on Teva Pha...
10/03/2025 12:21:58

JP Morgan analyst Chris Schott maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Overweight and raises the price target...

is-teva-pharmaceutical-indus-gaining-or-losing-market-support
Is Teva Pharmaceutical Indus Gaining or Lo...
09/24/2025 13:00:41

ubs-maintains-buy-on-teva-pharmaceutical-indus-raises-price-target-to-26
UBS Maintains Buy on Teva Pharmaceutical I...
09/24/2025 12:53:54

UBS analyst Ashwani Verma maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Buy and raises the price target from $23 to...

Core News & Articles
FDA Chief Says Leucovorin Will Be Made Ava...
09/22/2025 21:20:40

https://www.youtube.com/watch?v=esKFMCb_hYUhttps://www.youtube.com/watch?v=esKFMCb_hYU

reported-saturday-teva-announces-long-term-safety-findings-showing-no-post-injection-delirium-sedation-syndrome-in-patients-taking-olanzapine-lai-tev-749
Reported Saturday, Teva Announces Long Ter...
09/22/2025 06:53:23

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) eve...

reported-saturday-teva-reports-patients-with-tardive-dyskinesia-found-austedo-xr-easy-to-take-with-over-96-agreement
Reported Saturday, Teva Reports Patients W...
09/22/2025 06:50:12

Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AU...

trump-administration-to-unveil-tylenol-autism-review-tout-this-drug-as-potential-treatment-report
Trump Administration To Unveil Tylenol-Aut...
09/22/2025 05:36:39

Trump administration to announce concerns about Tylenol use in pregnancy and potential treatment for autism, in line with Presi...

teva-to-hold-conference-call-to-discuss-phase-3-solaris-trial-data-on-sept-22
Teva To Hold Conference Call To Discuss Ph...
09/16/2025 20:31:20

fda-grants-teva-pharmaceuticals-emrusolmin-fast-track-designation-for--multiple-system-atrophy
FDA Grants Teva Pharmaceutical's Emrusolmi...
09/09/2025 12:31:56

Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational ...

teva-launches-generic-glp-1-weight-loss-drug-with-fda-nod-for-saxenda
Teva Launches Generic GLP-1 Weight Loss Dr...
08/28/2025 18:58:18

Teva launches the first U.S. generic version of Saxenda for weight loss after FDA approval, expanding its portfolio with a key ...

teva-announces-fda-approval-of-generic-version-of-saxenda-liraglutide-injection
Teva Announces FDA Approval Of Generic Ver...
08/28/2025 12:35:06

Core News & Articles
10 Health Care Stocks With Whale Alerts In...
08/21/2025 17:35:27

how-is-the-market-feeling-about-teva-pharmaceutical-indus
How Is The Market Feeling About Teva Pharm...
08/18/2025 15:00:30

the-fda-approves-teva-pharmaceuticals-ajovy-for-the-preventive-treatment-of-episodic-migraine-in-children-and-adolescent-patients-aged-6-17-years-who-weigh-45-kilograms-99-pounds-or-more
The FDA Approves Teva Pharmaceuticals' Ajo...
08/06/2025 11:21:58

teva-pharma-boosts-outlook-for-key-innovative-drugs-austedo-ajovy-uzedy
Teva Pharma Boosts Outlook For Key Innovat...
07/30/2025 17:15:45

Teva raised 2025 guidance for Austedo, Ajovy, and Uzedy after Q2 earnings beat estimates, despite missing revenue expectations.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION